RavinderKGrewalMD

Nuclear Medicine • New York, NY

MSKCC

Join to view full profile

Dr. Grewal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grewal's full profile

Already have an account?

Office
1275 York Ave
New York, NY 10065
Phone+1 212-639-2000

Education & Training

Drexel University College of Medicine/Hahnemann University HospitalResidency, Nuclear Medicine, 2000 - 2002
Dayanand Medical College Class of 1996

Certifications & Licensure

NJ State Medical License 2007 - 2025
NY State Medical License 2002 - 2025
PA State Medical License 2000 - 2002
American Board of Nuclear Medicine Nuclear Medicine

Clinical Trials

Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer Start of enrollment: 2006 Jan 01
Completed
Phase 1
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma Start of enrollment: 2005 Mar 01
Active, not recruiting
Phase 1
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma Start of enrollment: 2018 Aug 21
Recruiting
Phase 1
Imaging With a PET Agent for Detection of Cancers of the Head and Neck Start of enrollment: 2018 Aug 10
Recruiting
Phase 1, Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

[F]TFB PET/CT misses intense [I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.
Philipp Backhaus, Keith S Pentlow, Alan L Ho, Audrey Mauguen, James A Fagin
EJNMMI Research. 2024-10-08
2 citations
Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dos...
Lisa Bodei, R Michael Tuttle, Ravinder K Grewal, Audrey Mauguen, Finn Augensen
European Journal of Nuclear Medicine and Molecular Imaging. 2024-01-01
2 citations
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction ...
Audrey Mauguen, Ravinder K Grewal, Finn Augensen, Murad Abusamra, Sonia Mahajan
European Journal of Nuclear Medicine and Molecular Imaging. 2023-08-01

Journal Articles

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Steven M Larson, Sofia Haque, Duan Li, R Michael Tuttle, Mona M Sabra, Alan L Ho, Eric J Sherman, Ravinder K Grewal, James A Fagin, David G Pfister, Ronald A Ghossein, The Journal of Clinical Endocrinology and Metabolism

Press Mentions

Las Vegas Is Waking up. This California Town on the Road There Is Struggling to Come Back to LifeJune 16th, 2020
Theranostics with RAI Offer a Precision Approach to Treating Differentiated Thyroid CancerJuly 29th, 2019
Abstracts for the Society of Nuclear Medicine and Molecular Imaging, Greater New York and New England Chapters, 31st Annual Northeast Regional Scientific Meeting, Mystic CT, November 3–5, 2017April 23rd, 2018